• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CTLA-4介导的T细胞增殖早期事件的抑制作用。

CTLA-4-Mediated inhibition of early events of T cell proliferation.

作者信息

Brunner M C, Chambers C A, Chan F K, Hanke J, Winoto A, Allison J P

机构信息

Howard Hughes Medical Research Institute, Cancer Research Laboratory, Department of Molecular and Cellular Biology, University of California, Berkeley, CA 94720, USA.

出版信息

J Immunol. 1999 May 15;162(10):5813-20.

PMID:10229815
Abstract

CTLA-4 engagement by mAbs inhibits, while CD28 enhances, IL-2 production and proliferation upon T cell activation. Here, we have analyzed the mechanisms involved in CTLA-4-mediated inhibition of T cell activation of naive CD4+ T cells using Ab cross-linking. CTLA-4 ligation inhibited CD3/CD28-induced IL-2 mRNA accumulation by inhibiting IL-2 transcription, which appears to be mediated in part through decreasing NF-AT accumulation in the nuclei. However, CTLA-4 ligation did not appear to affect the CD28-mediated stabilization of IL-2 mRNA. Further, CTLA-4 engagement inhibited progression through the cell cycle by inhibiting the production of cyclin D3, cyclin-dependent kinase (cdk)4, and cdk6 when the T cells were stimulated with anti-CD3/CD28 and with anti-CD3 alone. These results indicate that CTLA-4 signaling inhibits events early in T cell activation both at IL-2 transcription and at the level of IL-2-independent events of the cell cycle, and does not simply oppose CD28-mediated costimulation.

摘要

单克隆抗体与CTLA-4结合会抑制T细胞活化时的白细胞介素-2(IL-2)产生和增殖,而CD28则会增强这一过程。在此,我们利用抗体交联分析了CTLA-4介导的对初始CD4+ T细胞T细胞活化抑制作用的相关机制。CTLA-4连接通过抑制IL-2转录来抑制CD3/CD28诱导的IL-2 mRNA积累,这似乎部分是通过减少细胞核中活化T细胞核因子(NF-AT)的积累来介导的。然而,CTLA-4连接似乎并不影响CD28介导的IL-2 mRNA稳定。此外,当用抗CD3/CD28和单独抗CD3刺激T细胞时,CTLA-4结合通过抑制细胞周期蛋白D3、细胞周期蛋白依赖性激酶(cdk)4和cdk6的产生来抑制细胞周期进程。这些结果表明,CTLA-4信号传导在IL-2转录以及细胞周期中不依赖IL-2的事件水平上抑制T细胞活化早期的事件,而不仅仅是对抗CD28介导的共刺激作用。

相似文献

1
CTLA-4-Mediated inhibition of early events of T cell proliferation.CTLA-4介导的T细胞增殖早期事件的抑制作用。
J Immunol. 1999 May 15;162(10):5813-20.
2
Aging impairs induction of cyclin-dependent kinases and down-regulation of p27 in mouse CD4(+) cells.衰老会损害小鼠CD4(+)细胞中细胞周期蛋白依赖性激酶的诱导以及p27的下调。
Cell Immunol. 1999 Nov 25;198(1):11-20. doi: 10.1006/cimm.1999.1573.
3
Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.白细胞介素-10处理的人树突状细胞诱导的无反应性T细胞的抑制活性:与由p27Kip1调节的细胞周期中依赖白细胞介素-2和细胞毒性T淋巴细胞相关抗原4的G1期阻滞有关。
Eur J Immunol. 2003 Jul;33(7):1988-97. doi: 10.1002/eji.200323600.
4
Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.老年人T淋巴细胞进入细胞周期失败与Cdk6活性降低及Rb蛋白磷酸化受损有关。
Cell Immunol. 1999 Oct 10;197(1):46-54. doi: 10.1006/cimm.1999.1550.
5
Nonresponsiveness and susceptibility to CTLA-4 of antigen-exposed CD4 T cells are not regulated by the Bcl-2 family of apoptotic mediators, but can be restored by IL-2.抗原暴露的CD4 T细胞对CTLA-4的无反应性和敏感性不受凋亡介质Bcl-2家族的调节,但可通过IL-2恢复。
Thymus. 1997;24(4):259-77.
6
Inhibition of T cell proliferation by cholera toxin involves the modulation of costimulatory molecules CTLA-4 and CD28.霍乱毒素对T细胞增殖的抑制作用涉及共刺激分子CTLA-4和CD28的调节。
Immunol Lett. 2008 Jan 15;115(1):59-69. doi: 10.1016/j.imlet.2007.10.003. Epub 2007 Nov 5.
7
Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.通过CD28和CTLA-4发出的信号控制着两种不同形式的T细胞无能。
J Clin Invest. 2001 Sep;108(6):895-903. doi: 10.1172/JCI13220.
8
An inhibitor of CD28-CD80 interactions impairs CD28-mediated costimulation of human CD4 T cells.CD28-CD80相互作用的抑制剂会损害CD28介导的人CD4 T细胞共刺激。
Cell Immunol. 1999 Jan 10;191(1):49-59. doi: 10.1006/cimm.1998.1403.
9
Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.CTLA-4在调节静息记忆性与初始CD4 T细胞活化中的不同作用。
J Immunol. 1998 Dec 1;161(11):5855-61.
10
Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.糖皮质激素可诱导正常人受刺激淋巴细胞的G1期以及S期延长:对细胞周期调节蛋白的不同影响。
Exp Cell Res. 1998 May 1;240(2):263-73. doi: 10.1006/excr.1998.3942.

引用本文的文献

1
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy.用于个性化治疗和提高疗效的革命性癌症疗法:克服免疫检查点抑制剂疗法耐药性的策略
Cancers (Basel). 2025 Mar 4;17(5):880. doi: 10.3390/cancers17050880.
2
Immune checkpoint inhibitor-associated myocarditis: a historical and comprehensive review.免疫检查点抑制剂相关心肌炎:一项历史性的全面综述
Am J Physiol Heart Circ Physiol. 2025 Apr 1;328(4):H734-H751. doi: 10.1152/ajpheart.00687.2024. Epub 2025 Feb 10.
3
SLAMF7 (CD319) on activated CD8 T cells transduces environmental cues to initiate cytotoxic effector cell responses.
活化的CD8 T细胞上的信号淋巴细胞激活分子家族成员7(SLAMF7,即CD319)转导环境信号以启动细胞毒性效应细胞反应。
Cell Death Differ. 2025 Mar;32(3):561-572. doi: 10.1038/s41418-024-01399-y. Epub 2024 Oct 10.
4
Immune Checkpoints and Graves' Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review.免疫检查点与格雷夫斯病、甲状腺眼病和眼眶肌病:综述
J Ophthalmic Vis Res. 2024 Sep 16;19(3):368-380. doi: 10.18502/jovr.v19i3.15047. eCollection 2024 Jul-Sep.
5
Immune checkpoint inhibitors in infectious disease.传染病中的免疫检查点抑制剂。
Immunol Rev. 2024 Nov;328(1):350-371. doi: 10.1111/imr.13388. Epub 2024 Sep 9.
6
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 T cells.联合抗 PD-1 和抗 CTLA-4 治疗会产生包括祖细胞耗竭 CD8 T 细胞在内的克隆反应波。
Cancer Cell. 2024 Sep 9;42(9):1582-1597.e10. doi: 10.1016/j.ccell.2024.08.007. Epub 2024 Aug 29.
7
Resident memory T cells and cancer.常驻记忆 T 细胞与癌症。
Immunity. 2024 Aug 13;57(8):1734-1751. doi: 10.1016/j.immuni.2024.06.017.
8
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2).达维柳单抗(ALPN-202)的 I 期研究,一种 PD-L1 依赖性 CD28 共刺激剂和双重 PD-L1/CTLA-4 抑制剂,作为单药治疗以及联合帕博利珠单抗治疗晚期实体瘤(NEON-1 和 NEON-2)。
J Immunother Cancer. 2024 Aug 3;12(8):e009474. doi: 10.1136/jitc-2024-009474.
9
Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis.吞噬细胞与 T 细胞间的串扰及其与动脉粥样硬化的相关性。
Front Immunol. 2024 May 30;15:1403150. doi: 10.3389/fimmu.2024.1403150. eCollection 2024.
10
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy.植物化学物质/天然产物在癌症免疫治疗中的调节作用。
Curr Med Chem. 2024;31(32):5165-5177. doi: 10.2174/0109298673274796240116105555.